Lijuan Han Selected Research

LX009

7/2018

4-((5-(Tert-butyl)-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic acid protects against oxygen-glucose deprivation/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijuan Han Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 10/2011
9	Stroke (Strokes) 07/2018 - 02/2013
6	Inflammation (Inflammations) 01/2022 - 02/2013
3	Brain Injuries (Brain Injury) 04/2018 - 02/2013
3	Ischemic Stroke 01/2017 - 06/2012
2	COVID-19 01/2022 - 05/2021
2	Dysbiosis 01/2022 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 07/2020 - 03/2020
2	Hypoxia (Hypoxemia) 01/2020 - 06/2014
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Insulin Resistance 10/2018 - 04/2018
2	Ischemia 09/2015 - 01/2015
2	Rhinitis 10/2014 - 08/2014
2	Lymphoma (Lymphomas) 10/2014 - 08/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Infections 01/2022
1	Dehydration (Water Stress) 10/2020
1	Rupture 07/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Diarrhea 01/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2020
1	Atherosclerosis 10/2018
1	Neuroblastoma 07/2018
1	Reperfusion Injury 07/2018
1	Nervous System Diseases (Neurological Disorders) 04/2018
1	Obesity 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Memory Disorders (Memory Loss) 10/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2017
1	Pneumonia (Pneumonitis) 06/2016
1	Tracheomalacia 06/2016
1	Communicable Diseases (Infectious Diseases) 05/2016
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2015
1	Brain Ischemia (Cerebral Ischemia) 09/2015

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 04/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2020
2	Thrombopoietin ReceptorsIBA 11/2021 - 01/2016
2	CalreticulinIBA 11/2021 - 01/2016
2	LipidsIBA 10/2018 - 04/2018
2	Neuroprotective AgentsIBA 07/2018 - 10/2017
2	Oxygen (Dioxygen)IBA 07/2018 - 10/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2018 - 09/2015
2	LigandsIBA 04/2018 - 10/2014
2	CytokinesIBA 01/2017 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 06/2014
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Tight Junction ProteinsIBA 01/2022
1	EndoribonucleasesIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	CreatinineIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	lianhuaqingwenIBA 05/2021
1	AminesIBA 10/2020
1	AldehydesIBA 10/2020
1	polyglycerolIBA 10/2020
1	ZeinIBA 10/2020
1	EmulsionsIBA 10/2020
1	Excipients (Suspending Agents)IBA 10/2020
1	Tuberculin (PPD)IBA 07/2020
1	GinsenosidesIBA 07/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	EchinomycinIBA 01/2020
1	Emodin (Archin)IBA 01/2020
1	Hypoxia-Inducible Factor 1IBA 01/2020
1	InterferonsIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Dietary CholesterolIBA 10/2018
1	LX009IBA 07/2018
1	phenolic acidIBA 07/2018
1	AcidsIBA 07/2018
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	ThiazolidinedionesIBA 04/2018
1	Prorenin ReceptorIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018
1	EnzymesIBA 10/2017
1	cocaine- and amphetamine-regulated transcript proteinIBA 10/2017
1	Cocaine (Cocaine HCl)IBA 10/2017
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2017
1	Amyloid beta-PeptidesIBA 10/2017
1	Adenosine Monophosphate (AMP)IBA 03/2017
1	Mitogen-Activated Protein KinasesIBA 03/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	tanshinone II A sodium sulfonateIBA 01/2017
1	Ribosomal DNA (rDNA)IBA 06/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2016
1	AntioxidantsIBA 04/2016
1	2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA 04/2016
1	Janus Kinase 2IBA 01/2016
1	Bromodeoxyuridine (BrdU)IBA 09/2015
1	Rosiglitazone (Avandia)FDA Link 09/2015

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2015
2	Enema (Enemas) 01/2022 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 08/2015
1	Aftercare (After-Treatment) 01/2022
1	Nephrectomy 01/2022
1	Intravenous Administration 01/2017